×
Search your requirement
Search your requirement
Home
Press Releases
Submit Release
Events
Reach Us
Social media
Search
Home
Press Releases
Submit Release
Events
Reach Us
Search
MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing
Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics
Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season
OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award
Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis
ProJenX announces the formation of its Clinical Advisory Board
Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma
NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients
Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits
Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.
Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic
FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma
Featured Press Releases
Corundum Systems Biology appoints Jessica Schneider as Chief Scientific Officer
2025 Interim Results and Business Updates Announced by Innovent
27 Aug 2025
Innovent Biologics, Inc. a world-class biopharmaceutical company that develops, manufactures and
...
nuBioAge, nuHx, and Marius Pharmaceuticals launch a collaborative GLP-1 comparison study in male patients.
Next Generation Gene Therapeutics (NGGT) announces the publication of early clinical trial results for NGGT001, a treatment for Bietti's Crystalline Dystrophy (BCD)
Matisse Pharmaceuticals receives INN for M6229, recognizing it as a first-in-class drug, isupartob sodium
New ECCO data demonstrate that subcutaneous infliximab (Remsima™ SC) recaptures and maintains disease control following a drug holiday
Dunbar Pharma Brings First Plant-Derived Dronabinol API to the UK Market Through IPS Pharma
By
Dunbar Pharmaceuticals
Dunbar Pharmaceuticals
18 Aug 2026
Former DePuy Synthes U.S. President Joins Peptilogics Board
By
Peptilogics
Peptilogics
18 Aug 2026
PanTRKare™ Is Officially Approved as the Companion Diagnostic for VELMARTO® (Eratrectinib)
By
Jiangsu Vcare Pharmatech Co., Ltd.
Jiangsu Vcare Pharmatech Co., Ltd.
17 Aug 2026
Bruker and Atinary Technologies Join Forces to Accelerate the Future of Self-Driving Laboratories
By
Bruker Corporation
Bruker Corporation
11 Aug 2026
Neurolief Advances Veteran Mental Health and Migraine Care With New VA Contract for Prescription Neuromodulation
By
Neurolief Inc.
Neurolief Inc.
11 Aug 2026
Bruker Announces Majority Stake in MIMETAS to Accelerate Drug Discovery and Development Using Human Physiology-Relevant Models
By
Bruker Corporation
Bruker Corporation
10 Aug 2026
Log in
Username
Show
Remember Me
Log in
Create an account
Forgot your username?
Forgot your password?
Most Popular
VTAMA® (tapinarof) Cream, 1%, Demonstrates Early and Consistent Efficacy in Children Aged 2+ with Atopic Dermatitis, According to New Data
By
Organon & Co.
Nov 10
AI Utilized by TNF Pharmaceuticals and Renova Health to Accelerate Drug Development
By
TNF Pharmaceuticals, Inc.
Apr 22
JelloX Biotech Establishes U.S. Research Base
By
JelloX Biotech Inc.
Apr 15
August
2026
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
User Area
Login page
Registration
Edit Profile
Forgot Password
Discover
About Us
Terms Of Use
Privacy Policy
FAQs
Engage with Us
Search on Site
Post Press Release
Promote Brand
List Your Event
Subscribe to Our Monthly Newsletter
Subscribe to Pharmaceutical Era’s monthly newsletter,
Pharmaceutical Leaders Digest
®, to receive timely updates from across the pharmaceutical industry.
I agree with the
Terms and conditions
×
and the
Privacy policy
×
Please enable the javascript to submit this form
Subscribe
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. To find out more, please click
here
.
I understand
